Support- professional: other

Ended Awarded Jul 1, 2016 Last action Jun 3, 2021

Contract number: HHSN261201600018I
Awardee: Southern Research Institute UEI CDZJAJJHJMH5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 3 $375,692 obligated

Award facts

Opportunity: N02CM4700142 Solicitation number

Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
Combined order value: $375,692 Current and potential, with all options
Last date to order 100% complete: Jun 30, 2021
IDV ceiling 2% used: $19,000,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 541690 Other Scientific and Technical Consulting Services
PSC: R499 Support- Professional: Other
Set-aside: No set-aside
Competition: Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)
Legislative mandates: Service Contract Act FAR subpart 22.10

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Toxicology study of human complement factor H antibody GT103 in mice period of performance 12/19/2018 - 12/18/2019 75N91019F00090	National Cancer Institute (NIH)	$358,997	Dec 18, 2018
Pharmacokinetic study of human complement factor H antibody GT103 in mice period of performance: 5/15/2018 - 12/31/18… 75N91018F00002	National Cancer Institute (NIH)	$15,971	May 21, 2018
Initial administrative charges to#1 pre-clin TOX study of drug DEV for cancer patients HHSN261201600018I DTP-16-041 TPB HHSN26100001	National Cancer Institute (NIH)	$724	Jul 1, 2016

Action	Obligated	Date
Other Administrative Action P00003 · Preclinical toxicology of drugs developed for cancer patients	$0	Jun 3, 2021
Other Administrative Action 2 · Toxicology studies IDIQ period of performance 07/01/2016 - 06/30/2021	$0	Jun 11, 2018
Other Administrative Action 1	$0	Apr 6, 2017
Original award	$0	Jul 1, 2016

HHSN261201600018I was awarded to Southern Research Institute by National Cancer Institute (National Institutes of Health) on July 1, 2016.

Orders under HHSN261201600018I have obligated $375,692. HHSN261201600018I's own ceiling is $19,000,000.

3 orders have been placed under HHSN261201600018I, the latest on December 18, 2018.

HHSN261201600018I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201600018I is part of Toxicology of Drugs Developed for Cancer Patients.

The extent of competition for HHSN261201600018I was full and open competition. The government received 6 offers.

On GovTribe

Try for free Login